BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38615588)

  • 21. Generation of a human induced pluripotent stem cell line (MUSIi001-A) from caesarean section scar fibroblasts using Sendai viral vectors.
    Wattanapanitch M; Ritthaphai A; Park C; Boonkaew B; Netsrithong R; Pattanapanyasat K; Limsiri P; Vatanashevanopakorn C
    Stem Cell Res; 2018 Mar; 27():105-108. PubMed ID: 29367084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of the induced pluripotent stem cell line from a patient with autosomal recessive ABCA4-mediated Stargardt Macular Dystrophy.
    Claassen JN; Zhang D; Chen SC; Moon SY; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
    Stem Cell Res; 2019 Jan; 34():101352. PubMed ID: 30634128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of 5 induced pluripotent stem cell lines, LUMCi007-A and B and LUMCi008-A, B and C, from 2 patients with Huntington disease.
    van der Graaf LM; Gardiner SL; Tok M; Brands T; Boogaard MW; Pepers BA; Eussen B; de Klein A; Aziz NA; Freund C; Buijsen RAM; van Roon-Mom WMC
    Stem Cell Res; 2019 Aug; 39():101498. PubMed ID: 31326748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation.
    Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
    Stem Cell Res; 2016 Nov; 17(3):657-660. PubMed ID: 27934602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of an induced pluripotent stem cell line (FRIMOi007-A) derived from an incomplete achromatopsia patient carrying a novel homozygous mutation in PDE6C gene.
    Domingo-Prim J; Abad-Morales V; Riera M; Navarro R; Corcostegui B; Pomares E
    Stem Cell Res; 2019 Oct; 40():101569. PubMed ID: 31520890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of human-induced pluripotent stem cells from burn patient-derived skin fibroblasts using a non-integrative method.
    Fu S; Ding J; Liu D; Huang H; Li M; Liu Y; Tu L; Liu D
    Int J Mol Med; 2018 Jan; 41(1):87-94. PubMed ID: 29115387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling.
    Jin ZB; Okamoto S; Xiang P; Takahashi M
    Stem Cells Transl Med; 2012 Jun; 1(6):503-9. PubMed ID: 23197854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of an iPSC line (RMCGENi020-A) from a patient with Stargardt disease harboring the recurrent intronic ABCA4 variant c.4253+43G>A.
    Suárez-Herrera N; Leijsten N; Albert S; Bax NM; Hoyng CB; Cremers FPM; Garanto A; Collin RWJ
    Stem Cell Res; 2023 Dec; 73():103252. PubMed ID: 37979432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of an induced pluripotent stem (iPS) cell line from dermal fibroblasts of an asymptomatic patient with dominant PRPF31 mutation.
    Terray A; Fort V; Slembrouck A; Nanteau C; Sahel JA; Reichman S; Audo I; Goureau O
    Stem Cell Res; 2017 Dec; 25():26-29. PubMed ID: 29040912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of Footprint-Free Canine Induced Pluripotent Stem Cells Using Auto-Erasable Sendai Virus Vector.
    Tsukamoto M; Nishimura T; Yodoe K; Kanegi R; Tsujimoto Y; Alam ME; Kuramochi M; Kuwamura M; Ohtaka M; Nishimura K; Nakanishi M; Inaba T; Sugiura K; Hatoya S
    Stem Cells Dev; 2018 Nov; 27(22):1577-1586. PubMed ID: 30215317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprogramming of Primary Human Cells to Induced Pluripotent Stem Cells Using Sendai Virus.
    Draper JM; Vivian JL
    Methods Mol Biol; 2020; 2066():217-234. PubMed ID: 31512220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of an induced pluripotent stem cell (iPSC) line (BBANTWi009-A) from a Meester-Loeys syndrome patient carrying a BGN mutation.
    De Kinderen P; Rabaut L; Hebert A; Ponsaerts P; Perik M; Meester JAN
    Stem Cell Res; 2023 Feb; 66():103009. PubMed ID: 36599284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of an urine-derived induced pluripotent stem cell line from a 6-year old X-linked adrenoleukodystrophy (X-ALD) patient.
    Wang L; Gao B; Mo X; Guo X; Huang J
    Stem Cell Res; 2021 Mar; 51():102170. PubMed ID: 33472124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation of an induced pluripotent stem cell line from a patient carrying FBN1/c.6734 G > A mutation.
    Pan Z; Wang H; Wang H; Liu Y; Liang P
    Stem Cell Res; 2021 Aug; 55():102459. PubMed ID: 34298435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation and characterization of IMAGINi013-A, an induced pluripotent stem cell line generated from a healthy donor.
    Banal C; Lefort N
    Stem Cell Res; 2022 May; 61():102755. PubMed ID: 35334405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of induced pluripotent stem cell line NIMHi010-A from dermal fibroblast cells of a healthy individual.
    Dash SS; Arunachal G; Nimonkar MM; Vengalil S; Nashi S; Chetan GK; Boddu VK; Nalini A; Markandeya YS
    Stem Cell Res; 2024 Apr; 76():103355. PubMed ID: 38412659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of Footprint-Free Canine Induced Pluripotent Stem Cells from Peripheral Blood Mononuclear Cells Using Sendai Virus Vector.
    Tsukamoto M; Kimura K; Tanaka M; Kuwamura M; Ohtaka M; Nakanishi M; Sugiura K; Hatoya S
    Mol Reprod Dev; 2020 Jun; 87(6):663-665. PubMed ID: 32424848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of an induced pluripotent stem cell (iPSC) line (THSJTUi001-A) from a Wilson's disease patient harboring a homozygous Arg778Leu mutation in ATP7B gene.
    Wang SH; Wang XP
    Stem Cell Res; 2020 Dec; 49():102050. PubMed ID: 33096383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.